Life Science Instrumentation Market worth $92.5 billion by 2031
The report "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031", is projected to reach USD 92.5 billion by 2031 from USD 63.4 billion in 2025, at a CAGR of 6.5% from 2025 to 2030. The market growth is mainly driven by stricter regulatory requirements for product safety and quality control in the pharma-biopharma and food industries, along with an increase in investments in pharma-biopharma research and development (R&D). Additionally, growing collaboration between the public and private sectors is promoting innovation and speeding up technological progress. Moreover, emerging economies present significant growth opportunities due to rapid industrialization, expanding healthcare infrastructure, and increasing consumer awareness. All these factors are creating a positive environment for sustained market growth in the coming years.
Browse 300 market data Tables and 50 Figures spread through 400 Pages and in-depth TOC on "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html
The spectroscopy segment is expected to register a significant growth rate over the forecast period of 2025-2030
By technology, the life science instrumentation market is segmented into spectroscopy, chromatography, polymerase chain reaction (quantitative PCR, digital PCR), immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing, centrifuges, electrophoresis, cell counting, and other technologies. The spectroscopy segment held the largest share of the life science instrumentation market in 2025. The main factors driving spectroscopy technology in life science instrumentation include the rising demand for accurate molecular characterization and biomolecular analysis in research and diagnostic applications. Rapid progress in high-resolution detectors, laser technologies, and automation is significantly enhancing analytical sensitivity, accuracy, and throughput. Additionally, the expanding research pipeline for proteomics, metabolomics, and structural biology has boosted the adoption of spectroscopic techniques such as mass spectrometry, Raman spectroscopy, and infrared spectroscopy for comprehensive chemical and biological analysis profiling.
The research applications segment accounted for the largest share of the life science instrumentation market, by application, in 2025.
Based on applications, the life science instrumentation market is segmented into research applications, clinical & diagnostic applications, and other applications. The research applications segment held the largest share of the life science instrumentation market in 2025. The main factors driving research applications in life science instrumentation include the growing focus on studying complex biological systems through genomics, proteomics, and metabolomics research, which requires the use of advanced analytical and imaging technologies. Increased investments from government and academic institutions, along with expanding collaborations between research organizations and the biopharmaceutical industry, are further boosting the demand for advanced life science technology instruments.
The pharmaceutical & biotechnology companies segment accounted for the largest share of the life science instrumentation market, by end user, in 2025
By end user, the life science instrumentation market is segmented into hospitals and diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, agriculture & food industries, environmental testing laboratories, clinical research organizations, and other end users. The pharmaceutical & biotechnology companies segment accounted for the largest share of the life science instrumentation market in 2025. The main factors encouraging pharmaceutical and biotechnology companies to adopt life science instrumentation are the rising need for advanced analytical technologies that improve drug discovery, development, and quality control. The increasing prominence of biologics, biosimilars, and personalized medicine has further boosted the demand for highly precise instruments used in proteomics, genomics, and cell analysis. Additionally, rising regulatory requirements for data accuracy and product safety, along with advancements in automation, high-throughput screening, and digital analytics, are driving greater investment in advanced and sophisticated equipment instrumentation.
The Asia Pacific market is expected to register the highest growth in the market during the forecast period.
The Asia Pacific life science instrumentation market is expected to see the highest growth from 2025 to 2030, driven by rapid advancements in biotechnology, pharmaceuticals, and academic research. Major industry players are expanding their manufacturing and R&D capabilities in countries such as China, India, Japan, and South Korea to meet increasing regional demand. Growing government funding for life science research, increased healthcare spending, and the development of biopharma manufacturing hubs are further fueling market growth. Additionally, the rising adoption of analytical and diagnostic instruments in clinical laboratories, combined with a shift toward precision medicine and automation, creates significant growth opportunities for both global and regional players operating in the APAC life science instrumentation sector market.
As of 2025, prominent players in the life science instrumentation market are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and Hitachi High-Technologies Corporation (Japan), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Life Science Instrumentation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
